openPR Logo
Press release

Beta Glucan Based Products Market Projected to witness a Single Digit CAGR during 2018 - 2026 With Top Players Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH

05-04-2019 10:44 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Beta Glucan Based Products

Beta Glucan Based Products

The global beta glucan based products market size was valued at US$ 455.4 Mn in 2017 and is expected to witness a CAGR of 7.2% during the forecast period (2018 – 2026). Beta glucan is an important component of dietary fiber, which can be extracted from oat, barley, bacteria, and yeast. It possesses several physiological effects, including lowering plasma cholesterol level, control of postprandial glucose level, and immune modulation effects. Apart from the food industry, beta glucan is increasingly being used in the pharmaceutical, medical, cosmetic, and industrial applications, and end product manufacturing.

Download The PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2597

Βeta glucans can act as an immune system modulator and also has the ability to reduce blood glucose, and it may be used in the treatment of diabetes mellitus. Beta glucans can protect the body from heart attack by lowering cholesterol levels and it also acts as an anti-tumor agent. Beta glucans are used in medical field to treat various diseases including hyper cholesterolemia, diabetes, cancer, and HIV/AIDS.

Market Dynamics

Increasing applications of beta glucan as potential active ingredient in various food, medical, pharmaceutical, animal feed, and industrial applications is expected to increase demand for beta glucan and this is expected to aid in growth of the market in the near future. Moreover, health benefits of beta glucan along with changing consumer preferences towards use of nutritious food and dietary supplements among global population is expected to propel the market growth.

Furthermore, key players in the market are focusing on gaining significant market share by adopting various strategies and this is expected to aid in the market growth. For instance, in April 2017, Kemin Industries acquired a beta-glucan manufacturing technology from Algal Scientific, a company headquartered in Plymouth, U.S. In October 2014, NutraQ announced that it entered into a distribution partnership with American International Chemical LLC (AIC) to exclusively distribute NBG range of beta-glucans in in the U.S., Canada, and Mexico.

Changing consumer preferences towards the use of nutritious food supplements over synthetic ingredients is expected to drive the market growth during the forecast period Beta glucan is gaining interest among the population due to its multiple functional and bioactive properties. Beta glucan shows beneficial role in reducing insulin resistance, dyslipidemia, hypertension, and obesity. A study published in the Today’s Dietitian Journal: May 2014 stated that overweight men who consumed 7 g/day of beta-glucan for 12 weeks experienced a significant reduction in body mass, waist circumference, and visceral fat compared to those in the placebo group.

Increasing application of beta glucans in various infectious disease treatments is further expected to aid in the market growth

Various clinical and research studies support the application of beta glucan as a biological response modifier for the treatment of cancer and infectious diseases. However, the size and biochemical composition of β-glucans isolated from different sources affect their immunomodulatory properties.

Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2597

Beta glucans are used in medical field to treat various diseases such as hyper cholesterolemia, diabetes, cancer, and HIV/AIDS. Beta glucans act as modulator for immune system. Moreover, it is used in the treatment of various cancers such as pulmonary malignancy, prostate cancer, and breast cancer. Beta glucans are also used for treatment of various types of diseases that are correlated with immune system infections.

Key players operating in the beta glucan based products market include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc. and AIPPO.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Beta Glucan Based Products Market Projected to witness a Single Digit CAGR during 2018 - 2026 With Top Players Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH here

News-ID: 1727266 • Views:

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 2026 : Key Players are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2026
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Research Report 2018-2026
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insignificant CAGR Till 2025 With Top Players Novartis AG, Celgene Corp, Otsuka Pharmaceutical Co., Sandoz, Dr Reddys Laboratories, Pharmascience
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Beta

apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much! Apuem Finkenhofstraße 27 60322 Frankfurt am Main Germany Jacob Kearson support@apuem.com More Information: apuem.com/contact We and our community search for the best web apps
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026. Heat exchangers are devices that transfer energy between fluids
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Beta-lactam and Beta-lactamase
Global Beta Glucan Market Study 2018-2023 Gecono, Royal DSM, Super Beta Glucan
A market study "Global Beta Glucan Market" examines the performance of the Beta Glucan market 2018. It encloses an in-depth Research of the Beta Glucan market state and the competitive landscape globally. This report analyzes the potential of Beta Glucan market in the present and the future prospects from various angles in detail. The Global Beta Glucan Market 2018 report includes Beta Glucan market Revenue, market Share, Beta Glucan industry volume,
Global Catenin Beta 1 Market 2018 -Catenin Beta 1Propanac Biopharma Inc, Catenin …
Apex Market Reports, recently published a detailed market research study focused on the “Catenin Beta 1 Market” across the global, regional and country level. The report provides 360° analysis of “Catenin Beta 1 Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Catenin
Protein Kinase C Beta (PKC-Beta) Inhibitors Market show exponential growth by 20 …
The global market for protein kinase c beta (PKC-Beta) Inhibitors is increasing significantly. This increase in the market is majorly due to high efficacy of treatment for diabetes, cardiac disorder, cancer, and others has increased the scope for protein kinase c beta inhibitors. The advantage of long acting, specific and effective treatment of the diseases has increased the preference for protein kinase c beta inhibitors market. Request Sample Copy of the